NCT03744442 is a NA clinical trial of Dignity Therapy (DT) module in Life-limiting Serious Illness, sponsored by University Hospital, Basel, Switzerland.

Who is sponsoring NCT03744442?

NCT03744442 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT03744442?

Interventions in NCT03744442: Dignity Therapy (DT) module, CALM Therapy module, Mindfulness-based interventions module.

What condition does NCT03744442 study?

NCT03744442 studies Life-limiting Serious Illness.

Is NCT03744442 still recruiting?

NCT03744442 is currently completed. Last updated 11 April 2024.

Last reviewed 2024-04-11 · How we verify

NCT03744442

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Dignity, Meaningfulness and Mental Well-Being

Completed NA Last updated 11 April 2024

What this trial tests

NA trial testing Dignity Therapy (DT) module in Life-limiting Serious Illness in 10 participants. Completed in 15 November 2023.

Timeline

5 March 2020

Primary endpoint
30 September 2023

15 November 2023

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	10
Start date	5 March 2020
Primary completion	30 September 2023
Estimated completion	15 November 2023
Sites	1 location across Switzerland

Drugs / interventions tested

Dignity Therapy (DT) module
CALM Therapy module
Mindfulness-based interventions module

Conditions studied

Life-limiting Serious Illness — all drugs for Life-limiting Serious Illness →

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Life-limiting Serious Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Feasibility study to test the feasibility and acceptability of a designed personalized modular Intervention consisting of three modules, including Cancer and Living Meaningfully (CALM) Therapy, Dignity Therapy (DT), and a mindfulness-based Intervention

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03744442 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 11 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03744442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing